John A. Foekens mainly investigates Breast cancer, Internal medicine, Oncology, Cancer research and Cancer. His research integrates issues of Gene expression profiling, Metastasis, Immunology and Pathology in his study of Breast cancer. His Internal medicine study frequently draws connections between related disciplines such as Endocrinology.
His Oncology research is multidisciplinary, relying on both Survival analysis, Surgery, Urokinase, Multivariate analysis and Hazard ratio. His work deals with themes such as Regulation of gene expression, Wnt signaling pathway, Estrogen and Lung, which intersect with Cancer research. Cancer is a subfield of Genetics that John A. Foekens tackles.
Breast cancer, Internal medicine, Oncology, Cancer and Cancer research are his primary areas of study. The study incorporates disciplines such as Metastasis, Immunology and Pathology in addition to Breast cancer. John A. Foekens has researched Pathology in several fields, including Gene expression and Gene expression profiling.
Internal medicine connects with themes related to Endocrinology in his study. As a part of the same scientific study, John A. Foekens usually deals with the Oncology, concentrating on Plasminogen activator and frequently concerns with Urokinase. His Cancer research research focuses on DNA methylation and how it relates to Epigenetics.
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Cancer research and Cancer. John A. Foekens interconnects Immunohistochemistry, Primary tumor and Bioinformatics in the investigation of issues within Breast cancer. His Internal medicine research includes elements of Genotyping, Gynecology and Allele.
His Oncology study combines topics from a wide range of disciplines, such as Colorectal cancer, Circulating tumor cell, Cohort and Hazard ratio. His biological study spans a wide range of topics, including Cancer cell, Metastatic breast cancer, Immunology, Metastasis and Gene. His work carried out in the field of Cancer brings together such families of science as Retrospective cohort study, Regulation of gene expression, Transcriptome and Gene knockdown.
John A. Foekens mostly deals with Breast cancer, Cancer, Oncology, Internal medicine and Estrogen receptor. His Breast cancer research is multidisciplinary, incorporating elements of Camptothecin, Cancer research, Irinotecan and Bioinformatics. His Cancer research research incorporates elements of Cancer cell and Metastasis.
His Cancer research is multidisciplinary, incorporating perspectives in Transcriptome and Gene, Gene knockdown. The Oncology study combines topics in areas such as Circulating tumor cell, Cervical cancer, Retrospective cohort study, Hazard ratio and Prospective cohort study. The concepts of his Estrogen receptor study are interwoven with issues in Tamoxifen and Primary tumor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
Yixin Wang;Jan G M Klijn;Yi Zhang;Anieta M Sieuwerts.
The Lancet (2005)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
(2010)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos;Xiang H.-F. Zhang;Cristina Nadal;Weiping Shu.
Nature (2009)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo.
Nature (2012)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series,
Christine Desmedt;Fanny Piette;Sherene Loi;Yixin Wang.
Clinical Cancer Research (2007)
Complex landscapes of somatic rearrangement in human breast cancer genomes.
Philip J. Stephens;David J. Mcbride;Meng-lay Lin;Ignacio Varela.
Nature (2009)
Subtypes of Breast Cancer Show Preferential Site of Relapse
Marcel Smid;Yixin Wang;Yi Zhang;Anieta M. Sieuwerts.
Cancer Research (2008)
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
Sherene Loi;Benjamin Haibe-Kains;Christine Desmedt;Françoise Lallemand.
Journal of Clinical Oncology (2007)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
Maxime P. Look;Wim L. J. van Putten;Michael J. Duffy;Nadia Harbeck.
Journal of the National Cancer Institute (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Erasmus University Rotterdam
Erasmus University Rotterdam
Technical University of Munich
Radboud University Nijmegen
University of Copenhagen
University of Amsterdam
Johns Hopkins University
Oslo University Hospital
Wellcome Sanger Institute
Université Libre de Bruxelles
University of New South Wales
University of Delaware
Karlsruhe Institute of Technology
Hong Kong Baptist University
Japan Advanced Institute of Science and Technology
University of Cambridge
Vanderbilt University Medical Center
University of Florida
Seattle Genetics (United States)
University of California, Los Angeles
National Institutes of Health
Virginia Tech
Stony Brook University
Walter and Eliza Hall Institute of Medical Research
University of South Florida
McMaster University